Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 2/20 | 0.42 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28994883 | 0.98 | CSNK1D (0.41) | CSNK1DMAPK11MAPK14GABRA1GABRG2 | |
| SCHEMBL11204410 | 0.89 | GABRA1 (0.39) | CSNK1DMAPK11MAPK14GABRA1GABRG2 | |
| SCHEMBL5224988 | 0.84 | ALDH1A1 (0.54) | MAPK11MAPK14NPC1RAB9ACCNA2 | |
| SCHEMBL18766413 | 0.77 | NPC1 (0.38) | CSNK1DMAPK11MAPK14GABRA1GABRG2 | |
| SCHEMBL25274620 | 0.76 | CYP2A6 (0.43) | CSNK1DNPC1MAPK1RAB9ACDK2 | |
| SCHEMBL11775153 | 0.76 | L3MBTL1 (0.40) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL8893835 | 0.76 | MAPK1 (0.38) | CSNK1DGABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL22588702 | 0.76 | SMARCA2 (0.53) | NPC1MAPK1RAB9AADORA2AADORA1 | |
| SCHEMBL8891228 | 0.76 | BACE1 (0.44) | NPC1MAPK1RAB9ANOTUMTDO2 | |
| SCHEMBL10765951 | 0.76 | LMNA (0.42) | ALOX15NPC1MAPK1RAB9AADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 775 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12517282-B2 | Contact lenses containing light absorbing regions and methods for their preparation | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-01-06 | — | — | US | claimed |
| EP-4453642-A1 | CONTACT LENSES CONTAINING LIGHT ABSORBING REGIONS AND METHODS FOR THEIR PREPARATION | Johnson & Johnson Vision Care, Inc. (US) | 2024-10-30 | — | — | EP | claimed |
| US-20230296807-A1 | CONTACT LENSES CONTAINING LIGHT ABSORBING REGIONS AND METHODS FOR THEIR PREPARATION | JOHNSON & JOHNSON VISION CARE, INC. | 2023-09-21 | — | — | US | claimed |
| WO-2023119021-A1 | CONTACT LENSES CONTAINING LIGHT ABSORBING REGIONS AND METHODS FOR THEIR PREPARATION | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2023-06-29 | — | — | WO | claimed |
| CN-112851912-B | A3+ B2 type hyperbranched epoxy resin precursor, modified composition, preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2023-04-07 | — | — | CN | claimed |
| CN-112851911-B | Bio-based A2+ B3 type hyperbranched epoxy resin precursor, modified composition, preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2023-02-28 | — | — | CN | claimed |
| CN-112831027-B | Bio-based A3+ B2 type hyperbranched epoxy resin precursor, modified composition, preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2023-02-24 | — | — | CN | claimed |
| CN-111574747-B | Coordination crosslinking type polyimide aerogel and preparation method thereof | 陕西科技大学 | 2023-02-17 | — | — | CN | claimed |
| US-11571400-B2 | ACAT1 inhibitors for treating cancer | CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) | 2023-02-07 | — | — | US | claimed |
| CN-114797493-B | Temperature-resistant composite separation membrane and preparation method thereof | 西南石油大学 | 2023-01-31 | — | — | CN | claimed |
| US-5436399-A | Polycarbonateurethane copolymers chain extended by a diol, diamine, hydrazine or water; protective coatings; molding materials; synthetic leather; light, acid (oleic) and alcohol resistance; nonhydrolyziang | ASAHI KASEL KOGYO KABUSHIKI KAISHA (JP) | 1995-07-25 | — | — | US | claimed |
| EP-0446555-B1 | Polymeric diphenyldiamines | GOODYEAR TIRE & RUBBER (US) | 1994-09-21 | — | — | EP | claimed |
| EP-0614925-A1 | THERMOPLASTIC POLYURETHANE DERIVED FROM POLYTETRAMETHYLENE CARBONATE DIOL | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1994-09-14 | — | — | EP | claimed |
| EP-0499898-A2 | Polymeric diphenyldiamines | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1992-08-26 | — | — | EP | claimed |
| US-5075421-A | Antiozonants, curing agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1991-12-24 | — | — | US | claimed |
| EP-0446555-A1 | Polymeric diphenyldiamines | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1991-09-18 | — | — | EP | claimed |
| US-5049625-A | Ozone resistant rubber | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1991-09-17 | — | — | US | claimed |
| US-4931453-A | CARDIOVASCULAR, HYPOTENSIVE AGENTS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-06-05 | — | — | US | claimed |
| US-4149851-A | Concentrated aqueous dye compositions containing a low molecular weight amide | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER SANDOZ TRUST (US) | 1979-04-17 | — | — | US | claimed |
| US-4137219-A | STABILIZERS | BAYER AKTIENGESELLSCHAFT (DE) | 1979-01-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11571400-B2 | ACAT1 inhibitors for treating cancer | ACAT2, ACAT1, CEPT1 | CSNK1D 4758/4885MAPK11 3265/4885MAPK14 3595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.